RecruitingNCT06701214

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Discovering Outcomes in Clonal Hematopoiesis: The Clonal Hematopoiesis and Inflammation in VasculaturE (CHIVE) Registry and Biorepository


Sponsor

Vanderbilt-Ingram Cancer Center

Enrollment

800 participants

Start Date

Oct 28, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study will investigate the association between clonal hematopoiesis and other conditions. Clonal hematopoiesis (CH) refers to the mutations in a person's stem cells which commonly affect people as they get older. These mutations have notably been linked to increased risk of certain cancers as well as increased risk of heart disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood collection, Bone marrow collection, and others for people with clonal hematopoiesis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood collection

Blood will be taken from participants already undergoing blood collection

OTHERSaliva collection

Undergo saliva collection

OTHERBone marrow collection

Bone marrow will be taken from participants already undergoing bone marrow collection


Locations(1)

Vanderbilt University/Ingram Cancer Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06701214


Related Trials